Bruker Corporation (BRKR) Releases Earnings Results, Beats Expectations By $0.06 EPS

Bruker Corporation (BRKR) reported quarterly earnings results on Wednesday, May-4-2016. The company said it had a profit of $0.21 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.06. Analysts had a consensus of $0.15. The company posted revenue of $375.40 million in the period, compared to analysts expectations of $360.07 million. The company’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.14 EPS.

Many Wall Street Analysts have commented on Bruker Corporation. Bruker Corporation was Downgraded by Leerink Partners to ” Mkt Perform” on Apr 5, 2016. Bruker Corporation was Downgraded by BofA/Merrill to ” Underperform” on Apr 5, 2016. Company shares were Reiterated by Stifel on Mar 14, 2016 to “Buy”, Firm has raised the Price Target to $ 32 from a previous price target of $25 .

Bruker Corporation opened for trading at $28.47 and hit $28.79 on the upside on Monday, eventually ending the session at $28.76, with a gain of 1.63% or 0.46 points. The heightened volatility saw the trading volume jump to 17,33,608 shares. Company has a market cap of $4,700 M.

In a different news, on Mar 14, 2016, Mark Munch (Exec VP&Pres Bruker Nano Inc.) sold 75,000 shares at $27.70 per share price. According to the SEC, on Jun 17, 2015, Frank H Laukien (CEO) purchased 1,000,000 shares at $19.50 per share price. On Jun 15, 2015, Stephen W. Fesik (director) sold 15,000 shares at $20.48 per share price, according to the Form-4 filing with the securities and exchange commission.

Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research pharmaceuticals applied markets nanotechnology cell biology clinical research microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group the Bruker CALID Group and the Bruker Nano Group. BEST designs manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America and it has sales offices located throughout the world.

Bruker Corporation

Leave a Reply

Bruker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Bruker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.